Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-013629

CHIEF EXECUTIVE OFFICER sold 10,000 shares at an average $21.58 ($215,755)

  • CHIEF EXECUTIVE OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-16 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $2.14 $21,400 10,000 D
2024-05-16 Sale : show line 2 in the form 10b5-1 −8,707 $21.52 $187,410 1,293 D
2024-05-16 Sale : show line 3 in the form 10b5-1 −1,293 $21.92 $28,345 0 D
Open-market sales · 10,000 sh · avg $21.58 · $215,755

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-16 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −10,000 343,381 D
Loading xslF345X05/form4-05172024_070501.xml…